Cite
Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf. 1997;6:S79-90doi: 10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f.
Goettler, M., Schneeweiss, S., & Hasford, J. (1997). Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiology and drug safety, 6S79-90. https://doi.org/10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f
Goettler, M, et al. "Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission." Pharmacoepidemiology and drug safety vol. 6 (1997): S79-90. doi: https://doi.org/10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f
Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf. 1997 Oct;6:S79-90. doi: 10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f. PMID: 15073758.
Copy
Download .nbib